EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Asthma Phenotypes and Biomarkers

Jocelyn R Grunwell, Anne M Fitzpatrick

Respiratory Care · 2025

DOI: 10.1089/respcare.12352 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Respiratory Care, 2025. Verfasst von Jocelyn R Grunwell und 1 weiteren Autor:innen. Beteiligte Einrichtung: Dr. Grunwell is affiliated with Division of Critical Care Medicine, Department of Pediatrics, Children's Healthcare of Atlanta, Emory University Scho…. Hauptthemen laut MEDLINE: Asthma. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 241 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Asthma experienced by both adults and children is a phenotypically heterogeneous condition. Severe asthma, characterized by ongoing symptoms and airway inflammation despite high doses of inhaled and/or systemic corticosteroids, is the focus of research efforts to understand this underlying heterogeneity. Clinical phenotypes in both adult and pediatric asthma have been determined using supervised definition-driven classification and unsupervised data-driven clustering methods. Efforts to understand the underlying inflammatory patterns of severe asthma have led to the seminal discovery of type 2-high versus type 2-low phenotypes and to the development of biologics targeted at type 2-high inflammation to reduce the rates of severe asthma exacerbations. Type 2-high asthma is characterized by upregulation of T helper 2 immune pathways including interleukin (IL)-4, IL-5, and IL-13 along with eosinophilic airway inflammation, sometimes allergic sensitization, and responsiveness to treatment with corticosteroids. Type 2-low asthma is poorly responsive to corticosteroids and is not as well characterized as type 2-high asthma. Type 2-low asthma is limited by being defined as the absence of type 2-high inflammatory markers. Choosing a biologic for the treatment of severe asthma involves the evaluation of a panel of biomarkers such as blood eosinophils, total and specific immunoglobulin E/allergic sensitization, and fractional exhaled nitric oxide. In this review, we focus on the underlying pathobiology of adult and pediatric asthma, discuss the different phenotype-based treatment options for adult and pediatric type 2-high with or without allergic asthma and type 2-low asthma, and describe a clinical phenotyping approach to patients to guide out-patient therapy. Finally, we end with a discussion of whether pediatric asthma exacerbations necessitating admission to an ICU constitute their own high-risk phenotype and/or whether it is a part of other previously defined high-risk subgroups such as difficult-to-control asthma, exacerbation-prone asthma, and severe treatment-resistant asthma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AsthmaHumansPhenotypeBiomarkersChildAdultEosinophilsImmunoglobulin EAdrenal Cortex Hormones

Stichwörter der Autor:innen

allergic sensitizationasthmabiomarkerclusterendotypeexacerbationlatent class analysisphenotypetype-2 inflammation

Substanzen

BiomarkersImmunoglobulin EAdrenal Cortex Hormones

Autor:innen und Institutionen

  • Dr. Grunwell is affiliated with Division of Critical Care Medicine, Department of Pediatrics, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, Georgia.
  • Dr. Fitzpatrick is affiliated with Division of Pulmonary, Allergy/Immunology, Cystic Fibrosis, and Sleep Medicine, Department of Pediatrics, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta…

Förderung

  • NHLBI NIH HHS

Zitieren

APA

Grunwell, J. R., & Fitzpatrick, A. M. (2025). Asthma Phenotypes and Biomarkers. Respiratory Care. https://doi.org/10.1089/respcare.12352

Vancouver

Grunwell JR, Fitzpatrick AM. Asthma Phenotypes and Biomarkers. Respiratory Care. 2025. doi:10.1089/respcare.12352

BibTeX
@article{Grunwell2025,
  author = {Grunwell, Jocelyn R and Fitzpatrick, Anne M},
  title = {Asthma Phenotypes and Biomarkers},
  journal = {Respiratory Care},
  year = {2025},
  doi = {10.1089/respcare.12352}
}
Kostenlos starten →